Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Baird Initiates Coverage On Biohaven with Outperform Rating, Announces Price Target of $58

Author: Benzinga Newsdesk | December 08, 2023 06:52am
Baird analyst Brian Skorney initiates coverage on Biohaven (NYSE:BHVN) with a Outperform rating and announces Price Target of $58.

Posted In: BHVN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist